Aspirin use has been a matter of debate since quite long now, primarily for its role in the management and prevention of heart diseases. However, nobody ever wondered that scientists would one day prove if effective against several types of cancers.
A team of Chinese researchers recently claimed something that no one could ever have imagined. According to the latest study conducted by scientists at the Chinese University of Hong Kong, long-term of use of aspirin may reduce the risk of developing different types of cancers during a lifetime.
Are you struggling to find what you are looking for?Get Expert's Callback
The team of researchers independently conducted a study to look for the possible connection between aspirin use and cancer development. They looked at the data for more than 600,000 patients.
The researchers did find that patients taking aspirin every day for seven years were 38 percent less likely to get stomach cancer. Additionally, they were 47 percent less likely to get oesophageal and liver cancer.
The team did observe a marked reduction in the incidence of pancreatic and colorectal cancer as well. The overall incidence of cancer was quite less in people who were regular with aspirin use.
The results were substantial in the case of cancers related to the digestive system. However, the researchers did not observe the effect of aspirin on the incidence of kidney, breast, and bladder cancer. In addition, the incidence of multiple myeloma also remained the same.
Guneet Bhatia is an avid reader, healthcare writer, and is currently Director of Patient Care Department, MediGence. She has also been featured on many prominent Healthcare portals such as IBTimes, HCIT Expert, Clinician Today.